193 related articles for article (PubMed ID: 9099742)
1. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1.
Lahti JM; Li H; Kidd VJ
J Biol Chem; 1997 Apr; 272(16):10859-69. PubMed ID: 9099742
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
Kato JY; Sherr CJ
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11513-7. PubMed ID: 7505440
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
4. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.
Ajchenbaum F; Ando K; DeCaprio JA; Griffin JD
J Biol Chem; 1993 Feb; 268(6):4113-9. PubMed ID: 8382693
[TBL] [Abstract][Full Text] [Related]
5. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
7. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
8. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
Uchimaru K; Taniguchi T; Yoshikawa M; Asano S; Arnold A; Fujita T; Motokura T
Blood; 1997 Feb; 89(3):965-74. PubMed ID: 9028328
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
Musgrove EA; Lee CS; Buckley MF; Sutherland RL
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8022-6. PubMed ID: 8058751
[TBL] [Abstract][Full Text] [Related]
10. Development of mice expressing a single D-type cyclin.
Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle-dependent expression of cyclin D1 and a 45 kD protein in human A549 lung carcinoma cells.
Wu F; Bui KC; Buckley S; Warburton D
Am J Respir Cell Mol Biol; 1994 Apr; 10(4):437-47. PubMed ID: 8136159
[TBL] [Abstract][Full Text] [Related]
12. Physical interaction of the retinoblastoma protein with human D cyclins.
Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
[TBL] [Abstract][Full Text] [Related]
13. Selective usage of D-type cyclins in lymphoid malignancies.
Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
[TBL] [Abstract][Full Text] [Related]
14. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms.
Winston JT; Pledger WJ
Mol Biol Cell; 1993 Nov; 4(11):1133-44. PubMed ID: 8305735
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to mammalian D-type G1 cyclins.
Vallance SJ; Lee HM; Roussel MF; Shurtleff SA; Kato JY; Strom DK; Sherr CJ
Hybridoma; 1994 Feb; 13(1):37-44. PubMed ID: 8200657
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
17. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
Matsushime H; Ewen ME; Strom DK; Kato JY; Hanks SK; Roussel MF; Sherr CJ
Cell; 1992 Oct; 71(2):323-34. PubMed ID: 1423597
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
[TBL] [Abstract][Full Text] [Related]
19. Threshold expression of cyclin E but not D type cyclins characterizes normal and tumour cells entering S phase.
Gong J; Traganos F; Darzynkiewicz Z
Cell Prolif; 1995 Jun; 28(6):337-46. PubMed ID: 7626688
[TBL] [Abstract][Full Text] [Related]
20. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
